NEW YORK (GenomeWeb News) — Nanogen yesterday said fourth-quarter revenues increased 180 percent as R&D spending remained flat and net losses decreased 84 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $8.7 million from $3.1 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.